ADMA (ADMA Biologics Inc) Sof foyda

ADMA (ADMA Biologics, Inc.) - kompaniyaning tovar belgisi

ADMA Biologics foydani maksimallashtirish uchun o'zining xomashyo yig'ish markazlarini ishlab chiqish orqali plazma asosidagi dori vositalari segmentida ustunlikka intilmoqda. Immunodefitsit terapiyasi sohasidagi yetakchiligi FDA bio-chiqindilarni yo'q qilish qoidalariga qat'iy rioya qilish bilan to'ldirilgan. GURU.Markets platformasidagi kompaniyaning sof foyda grafigi ushbu tendentsiyani tasdiqlaydi, bunda parametr qiymati 0.17 ga teng bo'lib, haqiqiy moliyaviy o'sishni bozor shovqinlaridan ajratib ko'rsatadi.

ADMA (ADMA Biologics) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

ADMA Biologics, Inc. (ADMA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari ADMA Corp|ADMA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi ADMA Corp|ADMA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati ADMA Biologics|ADMA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi admabiologics.com|ADMA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati ADMA Biologics|ADMA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati ADMA Biologics Inc|ADMA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar ADMA Corp|ADMA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi ADMA Biologics|Shoshilinch likvidlik admabiologics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ADMA - Sof foyda
Kompaniyaning jamlanma tahlili:ADMA Biologics
ADMA Bio asosiy tovari

ADMA Biologics (ADMA) doirasida plazma yig'ish markazlarining va dori ishlab chiqarishning integratsiyasi kompaniyaning yillik moliyaviy natijalarida bevosita aks etgan bo'lib, uning yopiq sikli samaradorligini tasdiqlaydi. Ushbu ko'rsatkich barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyingi yakuniy sof foydani qamrab oladi, bu esa investorlarga biznesning pul oqimini yaratish bo'yicha haqiqiy qobiliyatini baholash va aktivning adolatli bozor qiymatini aniqlash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad PTGX (Protagonist)|IMVT (Immunovant Inc) - Yakuniy foyda|Sof foyda KNSA (Kiniksa Pharmaceuticals Ltd)|Sof moliyaviy natija Grifols Biemat (GRFS)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|NKTR - Sof foyda|UPB: Sof foyda|Kompaniya foydasi ZBIO|Kompaniyaning sof foydasi Immunome|Sof daromad Gossamer Bio Inc (GOSS)|Sof foyda KALV|Sof foyda Septerna Pharma (SEPN)|Pieris Pharmaceuticals - Sof daromad|Yakuniy foyda SVRA|Rigel Pharmaceuticals, Inc. - Sof foyda|ANAB: Kompaniyaning sof foydasi|ATXS: Sof foyda|ENGN - Sof moliyaviy natija|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|Kompaniyaning sof daromadi Aerovate JBIO|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|Kompaniyaning sof foydasi KYTX (Kyverna Therapeutics Inc.)|Kompaniyaning sof foydasi Tiziana Life Sciences PLC TLSA|Cabaletta Bio Inc (CABA) - Kompaniyaning sof daromadi|Ventyx Biosciences - Sof foyda|Yillik sof foyda theratech.com (THTX)|AVTX: Sof foyda|ELDN - Sof moliyaviy natija|AGEN (Agenus Inc) - Sof foyda|Sof daromad Climb Bio, Inc (CLYM)|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|Sof moliyaviy natija atyrpharma.com|Sof foyda ADAG (Adagene Inc.)|Sof foyda ImageneBio IMA|Shattuck Therapeutics - Sof foyda|EQ (Equillium, Inc.) - Kompaniya foydasi|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Sof daromad Immunic|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Sof foyda InflaRx GmbH|Kompaniyaning sof foydasi X4 Pharma (XFOR)|ACET: Soliqdan keyingi foyda|Sof foyda CELU (Celularity)|Yakuniy foyda INMB|Barinthus Biotherapeutics plc - Sof foyda|KZR - Sof foyda|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Akari Therapeutics, Plc - Yakuniy foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Sof daromad Q32 Bio Corp (QTTB)|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|iBio Corp - Sof daromad|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|Sof moliyaviy natija Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof daromad GRI (GRI Bio, Inc.)|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB: Kompaniya foydasi|Indaptus - Sof foyda|Kompaniyaning sof daromadi BiondVax Pharmaceuticals|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|ALLK (Allakos Inc) - Sof foyda|Kompaniya foydasi HOOK (HOOKIPA)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof foyda tcbiopharm.com TCBP|THRD: Sof daromad